Shopping Cart 0
Cart Subtotal
AED 0

Intec Pharma Ltd (NTEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company's pipeline products include drug indications for Parkinson's disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solution to drugs that have poor solubility, poor colonic absorption or act locally in upper gastrointestinal part. Intec Pharma offers products for various therapeutic areas including the central nervous system, the cardiovascular system, and gastrointestinal and infectious diseases. It has collaborations with pharmaceutical and biopharmaceutical companies. Intec Pharma is headquartered in Jerusalem, Israel.

Intec Pharma Ltd (NTEC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Intec Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Intec Pharma Enters into Agreement with LTS Lohmann Therapie 10

Intec Pharma Enters into Research Agreement with Biogen MA 11

Licensing Agreements 13

Intec Pharma Enters into Agreement with Novartis Pharma 13

Intec Pharma Enters into Licensing Agreement with a Pharma Company 14

Equity Offering 15

Intec Pharma Raises USD35.4 Million in Public Offering of Shares 15

Intec Pharma Raises USD57.5 Million in Public Offering of Shares 17

Intec Pharma Raises USD10 Million in Private Placement of Shares 18

Intec Pharma Completes Public Offering of Shares for USD34 Million 19

Intec Pharma Ltd-Key Competitors 21

Intec Pharma Ltd-Key Employees 22

Intec Pharma Ltd-Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Financial Announcements 24

Aug 15, 2018: Intec Pharma announces second quarter 2018 financial results 24

May 15, 2018: Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update 26

Mar 09, 2018: Intec Pharma Announces Fourth Quarter and Year End 2017 Financial Results 28

Nov 15, 2017: Intec Pharma Reports Third Quarter 2017 Operating and Financial Results 31

Aug 09, 2017: Intec Pharma Reports Financial Results for the First Six Months of 2017 33

Apr 07, 2017: Intec Pharma Reports 2016 Fourth Quarter and Full Year Financial Results 35

Corporate Communications 37

Jun 29, 2018: Intec Pharma Appoints William Bradley Hayes to Board of Directors 37

Mar 26, 2018: Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors 38

Nov 01, 2017: Intec Pharma Announces Changes to its Board of Directors 39

Oct 26, 2017: Intec Pharma Names Walt Linscott as Chief Administrative Officer 40

Jul 27, 2017: Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer 41

Jul 10, 2017: Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer 42

May 03, 2017: Intec Pharma Announces CEO Change 43

Apr 09, 2017: Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman 44

Clinical Trials 45

Aug 03, 2017: Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies 45

Mar 22, 2017: Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Intec Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Intec Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Intec Pharma Enters into Agreement with LTS Lohmann Therapie 10

Intec Pharma Enters into Research Agreement with Biogen MA 11

Intec Pharma Enters into Agreement with Novartis Pharma 13

Intec Pharma Enters into Licensing Agreement with a Pharma Company 14

Intec Pharma Raises USD35.4 Million in Public Offering of Shares 15

Intec Pharma Raises USD57.5 Million in Public Offering of Shares 17

Intec Pharma Raises USD10 Million in Private Placement of Shares 18

Intec Pharma Completes Public Offering of Shares for USD34 Million 19

Intec Pharma Ltd, Key Competitors 21

Intec Pharma Ltd, Key Employees 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Intec Pharma Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company's pipeline products include drug indications for Parkinson's disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solution to drugs that have poor solubility, poor colonic absorption or act locally in upper gastrointestinal part. Intec Pharma offers products for various therapeutic areas including the central nervous system, the cardiovascular system, and gastrointestinal and infectious diseases. It has collaborations with pharmaceutical and biopharmaceutical companies. Intec Pharma is headquartered in Jerusalem, Israel.

Intec Pharma Ltd (NTEC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Intec Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Intec Pharma Enters into Agreement with LTS Lohmann Therapie 10

Intec Pharma Enters into Research Agreement with Biogen MA 11

Licensing Agreements 13

Intec Pharma Enters into Agreement with Novartis Pharma 13

Intec Pharma Enters into Licensing Agreement with a Pharma Company 14

Equity Offering 15

Intec Pharma Raises USD35.4 Million in Public Offering of Shares 15

Intec Pharma Raises USD57.5 Million in Public Offering of Shares 17

Intec Pharma Raises USD10 Million in Private Placement of Shares 18

Intec Pharma Completes Public Offering of Shares for USD34 Million 19

Intec Pharma Ltd-Key Competitors 21

Intec Pharma Ltd-Key Employees 22

Intec Pharma Ltd-Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Financial Announcements 24

Aug 15, 2018: Intec Pharma announces second quarter 2018 financial results 24

May 15, 2018: Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update 26

Mar 09, 2018: Intec Pharma Announces Fourth Quarter and Year End 2017 Financial Results 28

Nov 15, 2017: Intec Pharma Reports Third Quarter 2017 Operating and Financial Results 31

Aug 09, 2017: Intec Pharma Reports Financial Results for the First Six Months of 2017 33

Apr 07, 2017: Intec Pharma Reports 2016 Fourth Quarter and Full Year Financial Results 35

Corporate Communications 37

Jun 29, 2018: Intec Pharma Appoints William Bradley Hayes to Board of Directors 37

Mar 26, 2018: Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors 38

Nov 01, 2017: Intec Pharma Announces Changes to its Board of Directors 39

Oct 26, 2017: Intec Pharma Names Walt Linscott as Chief Administrative Officer 40

Jul 27, 2017: Intec Pharma Promotes Nadav Navon, Ph.D. to Chief Operating Officer 41

Jul 10, 2017: Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer 42

May 03, 2017: Intec Pharma Announces CEO Change 43

Apr 09, 2017: Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman 44

Clinical Trials 45

Aug 03, 2017: Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies 45

Mar 22, 2017: Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Intec Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Intec Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Intec Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Intec Pharma Enters into Agreement with LTS Lohmann Therapie 10

Intec Pharma Enters into Research Agreement with Biogen MA 11

Intec Pharma Enters into Agreement with Novartis Pharma 13

Intec Pharma Enters into Licensing Agreement with a Pharma Company 14

Intec Pharma Raises USD35.4 Million in Public Offering of Shares 15

Intec Pharma Raises USD57.5 Million in Public Offering of Shares 17

Intec Pharma Raises USD10 Million in Private Placement of Shares 18

Intec Pharma Completes Public Offering of Shares for USD34 Million 19

Intec Pharma Ltd, Key Competitors 21

Intec Pharma Ltd, Key Employees 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Intec Pharma Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.